Systech Names Mark Quinlan SVP, Sales

PRINCETON, N.J.--(BUSINESS WIRE)--Systech International, a global leader in brand protection technologies, has appointed Mark Quinlan senior vice president of sales. Quinlan will lead a newly restructured and expanded global sales team.

"Mark's extensive experience in launching new products, global sales and marketing and executive sales leadership make him a strong asset for our strategic global sales initiative"

"Mark is a great fit for our rapidly expanding organization," said Robert DeJean, CEO, Systech. "He's aggressive, driven and has the vision and experience we need to outpace the competition and amplify our position as the global industry leader."

In 2014, the company experienced significant double-digit growth and a record number of new customer contracts. This year is also shaping up to be a high growth year due to expanded demand for its supply chain solutions that address the needs of enterprise serialization, track and trace, authentication and anti-counterfeiting.

DeJean noted that Quinlan will be focusing on the company's global market expansion in key regions such as the US, Europe, Latin America and Asia, where the company has a strong and growing base of business, primarily in the life sciences space. Systech currently has a significant number of pharmaceutical companies relying on its products and solutions to protect their brands and ensuring Systech's distribution channel is optimized to serve these markets.

Moreover, Quinlan will be driving accelerated global growth and leading expansion into new markets that have a strong need for the company's anti-counterfeiting solutions.

"Mark's extensive experience in launching new products, global sales and marketing and executive sales leadership make him a strong asset for our strategic global sales initiative," noted DeJean.

Quinlan comes to Systech from Technicote, Inc., a $100+ million manufacturer of pressure sensitive label material for the Label converting industry in the Americas. Prior to that, he worked with Esko Graphics Inc., a $300 million global leader in software and hardware solutions for the packaging industry.

"I'm excited at the possibilities here at Systech," said Quinlan. "The company not only invented the serialization marketplace, it is now redefining the space with the next iteration of brand protection products for the 21st Century. I can't think of a better, more exciting time to be part of the industry and this company in particular."

About Systech International

Systech is the global technology leader in product safety, and consumer and brand protection. Systech pioneered serialization and is defining the future of authentication.

Trusted by 19 of the top 20 pharmaceutical companies, Systech unifies and optimizes enterprise serialization, track and trace, and authentication technologies to ensure regulatory compliance, mitigate risk, and drive efficiency and profitability.

For 30 years, Systech's innovation has led best practices for key brands across the pharmaceutical, life science, food and beverage, and consumer packaged goods industries.

Contacts

Ann Willets, 908-433-7821
Public Relations Representative for Systech International
[email protected]

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

Janssen is tapping little-known and privately held Hemera Biosciences for a new gene therapy aimed at reversing a severe disease.

Harvard scientists showed that a three-gene cocktail, by epigenetic reprogramming, could reverse the aging clock in mice retina nerve cells.

Merck is clearly still buzzing about its two-year Dragonfly Therapeutics pact, as it has snapped up a cancer program.